Skip to main content

Anavo Therapeutics

Leiden, The Netherlands

Anavo Therapeutics provides therapeutic potential of human phosphatase biology.

$9.4M raised
May 2023
Seed

Top Investors

InkefMRL Ventures FundTaiho VenturesM VenturesBioqube Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anavo Therapeutics

How much funding has Anavo Therapeutics raised?
Anavo Therapeutics has raised $9.4M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Who are Anavo Therapeutics's investors?
Anavo Therapeutics's investors include Inkef, MRL Ventures Fund, Taiho Ventures, M Ventures, Bioqube Ventures.
Where is Anavo Therapeutics headquartered?
Anavo Therapeutics is headquartered in Leiden, The Netherlands.
What does Anavo Therapeutics do?
Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
What stage is Anavo Therapeutics at?
Anavo Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Anavo Therapeutics — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/anavo-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2023). Anavo Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/anavo-therapeutics
Wikipedia (cite web)
{{cite web |title=Anavo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/anavo-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .